A Randomized Trial Comparing Disease Activity Measures for the Assessment and Prediction of Response in Rheumatoid Arthritis Patients Initiating Certolizumab Pegol

Por Curtis, Jeffrey R., Churchill, Melvin, Kivitz, Alan, Samad, Ahmed, Gauer, Laura, Gervitz, Leon, Koetse, Willem, Melin, Jeffrey, Yazici, Yusuf
Publicado no Arthritis Rheumatol (2015)

Safety and efficacy of switching from adalimumab to sarilumab in patients with rheumatoid arthritis in the ongoing MONARCH open-label extension

Por Burmester, Gerd R, Strand, Vibeke, Rubbert-Roth, Andrea, Amital, Howard, Raskina, Tatiana, Gómez-Centeno, Antonio, Pena-Rossi, Claudia, Gervitz, Leon, Thangavelu, Karthinathan, St John, Gregory, Boklage, Susan, Genovese, Mark C
Publicado no RMD Open (2019)